Skip to content

The Effects of Pelvic Floor Muscle Training in Women With Overactive Bladdder

The Effects of Pelvic Floor Muscle Training in Women With Overactive Bladdder

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04950556
Enrollment
40
Registered
2021-07-06
Start date
2021-07-31
Completion date
2022-08-31
Last updated
2021-07-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Overactive Bladder

Brief summary

The aim of our study is to investigate the effects of pelvic floor muscle training (PFMT) on pelvic floor muscle strength, sexual functions, bladder symptoms and quality of life in women with overactive bladder (OAB).

Detailed description

Overactive bladder (OAB) is defined by the International Continence Association as an urgency with or without urge urinary incontinence, often accompanied by frequency and nocturia. Accordingly, pelvic floor muscle training (PFMT) plays an important role in the management of OAB. However, a recent systematic review suggests that PFMT is insufficient against OAB.

Interventions

OTHERExercise

Pelvic floor muscle exercise will be given to the exercise group

OTHERControl

No intervention

Sponsors

Ataturk Training and Research Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Intervention model description

Participants will be randomly divided into two groups (control and exercise) for treatment.

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Having a diagnosis of overactive bladder * Being volunteer

Exclusion criteria

* have a neurological disorder * only those with stress urinary incontinence * presence of advanced pelvic organ prolapse (stage 3-4) * Having a mental problem that will prevent cooperation in evaluation and / or applications * Women with the presence of malignant condition

Design outcomes

Primary

MeasureTime frameDescription
Pelvic floor muscle strengthchange from baseline at 6 weeksThe pelvic floor muscle strength of the patients will be evaluated by digital palpation. Change in pelvic floor muscle strength as measured with the Modified Oxford Scale, which ranges from 0 to 5
Sexual Functionchange from baseline at 6 weeksFemale sexual function will be assessed using the Female Sexual Function Index. This 19-question questionnaire deals with the subject in a multidimensional way by questioning the states of desire, arousal, lubrication, orgasm, satisfaction and pain. The highest raw score that can be obtained from the questionnaire is 95, and the lowest raw score is 4.

Secondary

MeasureTime frameDescription
OAB symptomschange from baseline at 6 weeksOAB symptoms will be evaluated OAB-V8. There are 8 questions in this form and the answers given to each question are scored between 0 and 5. The scores that can be obtained from the entire scale range from 0 to 40.
Urinary frequency, nocturia and the number of urinary incontinencechange from baseline at 6 weeksPatients will be also instructed to keep voiding diary
Life qualitychange from baseline at 6 weeksLife quality will be assessed with King's Health Questionnaire (KHQ).This questionnaire consists of two parts and 32 items.. The minimum possible score is 0 (best health) and the maximum possible score is 100 (worst health).

Contacts

Primary ContactSeyda Toprak Celenay
sydtoprak@hotmail.com+90312 906 1000

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026